Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Early Stage vs. Growth Stage

    Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Ear…

    FromProject Medtech

    Start listeningView podcast show

    Episode 117 | Alison Burklund, Co-Founder & CTO at Nanopath and Kate Rumrill, President and CEO at Ablative Solutions | Two Medtech Entrepreneurs: Ear…

    FromProject Medtech

    ratings:
    Length:
    45 minutes
    Released:
    Nov 14, 2022
    Format:
    Podcast episode

    Description


    In this episode, Alison Burklund, Kate Rumrill and Duane Mancini discuss their Medtech companies, comparing and contrasting raising money at a series D vs. series A, culture at a series A vs series D, coming into the CEO role vs. being a co-founder, and so much more.
    Alison Burklund LinkedIn
    Nanopath Website
    Kate Rumrill LinkedIn
    Ablative Solutions Website
    Project Medtech Website
    Duane Mancini LinkedIn
    Project Medtech LinkedIn
    Released:
    Nov 14, 2022
    Format:
    Podcast episode

    Titles in the series (100)

    Join us as we sit down with leading experts in the Medtech Industry as they share success stories, advice, pitfalls, trends and innovations.